Coral Laboratories Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 476417, "name": "Coral Labs.", "stock_name": "Coral Labs.", "full_name": "Coral Laboratories Ltd", "name_url": "stocks-analysis/coral-labs", "exchange": 0, "exchangecode": "", "primexch": 0, "country_id": 34, "currency": "INR", "cmp": "574.35", "chg": -5.65, "chgp": "-0.97%", "dir": -1, "prev_price": "580.00", "mcapval": "207.00 Cr", "mcap": "Micro Cap", "scripcode": 524506, "symbol": "", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE683E01017", "curr_date": "Jul 31, 03:30 PM", "curr_time": "21:41 PM", "last_traded_at": "Jul 31, 03:30 PM IST", "bse_nse_vol": "387 ", "exc_status": "Active", "traded_date": "Jul 31, 2026", "traded_date_str": "2026 07 31", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/coral-labs-476417-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Coral Laboratories Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/coral-laboratories-ltd-is-rated-hold-4124103", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/CoralLaboratori_mojoScore_4124103.png", "date": "2026-07-28 10:10:37", "description": "Coral Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 24 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Coral Laboratories Ltd Valuation Shifts Signal Renewed Price Attractiveness", "link": "https://www.marketsmojo.com/news/stocks-in-action/coral-laboratories-ltd-valuation-shifts-signal-renewed-price-attractiveness-4108363", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/CoralLaboratori_valuationdot_4108363.png", "date": "2026-07-20 08:00:29", "description": "Coral Laboratories Ltd has seen a notable shift in its valuation parameters, moving from a fair to an attractive rating as of late June 2026. This change comes despite a modest day decline of 1.16% and amid a challenging pharmaceutical sector landscape, highlighting a potential opportunity for investors seeking value in the micro-cap space." }, { "title": "Coral Laboratories Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/coral-laboratories-ltd-is-rated-hold-4106196", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/CoralLaboratori_mojoScore_4106196.png", "date": "2026-07-17 10:10:42", "description": "Coral Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 24 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing." }, { "title": "Coral Laboratories Ltd Valuation Turns Attractive Amid Sector Pressure", "link": "https://www.marketsmojo.com/news/stocks-in-action/coral-laboratories-ltd-valuation-turns-attractive-amid-sector-pressure-4092675", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/CoralLaboratori_valuationdot_4092675.png", "date": "2026-07-08 08:00:27", "description": "Coral Laboratories Ltd has seen a notable shift in its valuation parameters, moving from a fair to an attractive rating, despite a recent dip in share price. This change comes amid a challenging environment for the Pharmaceuticals & Biotechnology sector, where many peers remain expensive or risky. Investors are now reassessing Coral Labs’ price-to-earnings and price-to-book ratios, which appear compelling relative to both historical averages and industry benchmarks." }, { "title": "Coral Laboratories Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/coral-laboratories-ltd-is-rated-hold-4090554", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/CoralLaboratori_mojoScore_4090554.png", "date": "2026-07-06 10:11:01", "description": "Coral Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 24 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 July 2026, providing investors with an up-to-date view of its fundamentals, returns, and market standing." }, { "title": "Coral Laboratories Gains 13.94%: 7 Key Factors Driving the Surge", "link": "https://www.marketsmojo.com/news/stocks-in-action/coral-laboratories-gains-1394-7-key-factors-driving-the-surge-4075573", "imagepath": "", "date": "2026-06-27 17:05:45", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>22 Jun:</strong> New 52-week high (Rs.640)</p>\n <p><strong>23 Jun:</strong> New 52-week high (Rs.643.9) and valuation shift</p>\n <p><strong>24 Jun:</strong> New 52-week high (Rs.658.85) and Golden Cross formation</p>\n <p><strong>25 Jun:</strong> New 52-week high (Rs.659) and upgrade to Hold rating</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.549.45</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.626.05</div><div class=\"sta..." }, { "title": "Broad-Based Technical Strength Lifts Coral Laboratories Ltd to 52-Week High of Rs 659", "link": "https://www.marketsmojo.com/news/stocks-in-action/coral-laboratories-ltd-hits-new-52-week-high-at-rs659-4072999", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/CoralLaboratori_priceRelatedfactors_4072999.png", "date": "2026-06-25 10:10:53", "description": "With every major moving average and key technical indicator signalling strength, Coral Laboratories Ltd surged to a fresh 52-week high of Rs 659, marking a significant milestone in its price momentum despite a slight pullback on the day." }, { "title": "Coral Laboratories Ltd Upgraded to Hold as Technicals Improve and Valuation Stabilises", "link": "https://www.marketsmojo.com/news/stock-recommendation/coral-laboratories-ltd-upgraded-to-hold-as-technicals-improve-and-valuation-stabilises-4072590", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/CoralLaboratori_mojoScore_4072590.png", "date": "2026-06-25 08:14:08", "description": "Coral Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 24 June 2026. This change reflects a nuanced improvement across technical indicators, valuation metrics, and financial trends, despite some lingering concerns over profitability and growth. The stock’s recent performance and market positioning warrant a closer examination of the factors driving this reassessment." }, { "title": "Golden Cross Forms in Coral Laboratories Ltd Amid Mixed Technical Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/coral-laboratories-ltd-forms-golden-cross-signalling-potential-bullish-breakout-4071042", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/CoralLaboratori_goldencross_4071042.png", "date": "2026-06-24 18:05:25", "description": "The 50-day moving average has crossed above the 200-day moving average for Coral Laboratories Ltd, signalling a golden cross on 24 Jun 2026. Yet, the broader technical landscape presents a nuanced picture, with weekly indicators largely bullish but monthly momentum remaining bearish. This divergence raises questions about the strength and reliability of the signal in the current context." } ], "total": 187, "sid": "476417", "stock_news_url": "https://www.marketsmojo.com/news/coral-laboratories-476417" }, "announcements": [ { "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report", "datetime": "23-Jul-2026", "details": "Postal ballot e-voting results alongwith Scrutinizers Report", "source": "BSE" }, { "caption": "Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot", "datetime": "23-Jul-2026", "details": "Outcome of Postal ballot result alongwith Scrutinizer Report", "source": "BSE" }, { "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018", "datetime": "14-Jul-2026", "details": "Certificate under Regulation 74(5) of the SEBI (DP) Regulations 2018", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Coral Laboratories Ltd has declared <strong>15%</strong> dividend, ex-date: 19 Sep 25", "dt": "2025-09-19", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

22 Jun: New 52-week high (Rs.640)

23 Jun: New 52-week high (Rs.643.9) and valuation shift

24 Jun: New 52-week high (Rs.658.85) and Golden Cross formation

25 Jun: New 52-week high (Rs.659) and upgrade to Hold rating

Read full news article

Broad-Based Technical Strength Lifts Coral Laboratories Ltd to 52-Week High of Rs 659

2026-06-25 10:10:53

With every major moving average and key technical indicator signalling strength, Coral Laboratories Ltd surged to a fresh 52-week high of Rs 659, marking a significant milestone in its price momentum despite a slight pullback on the day.

Read full news article

Coral Laboratories Ltd Upgraded to Hold as Technicals Improve and Valuation Stabilises

2026-06-25 08:14:08

Coral Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 24 June 2026. This change reflects a nuanced improvement across technical indicators, valuation metrics, and financial trends, despite some lingering concerns over profitability and growth. The stock’s recent performance and market positioning warrant a closer examination of the factors driving this reassessment.

Read full news article

Golden Cross Forms in Coral Laboratories Ltd Amid Mixed Technical Signals

2026-06-24 18:05:25

The 50-day moving average has crossed above the 200-day moving average for Coral Laboratories Ltd, signalling a golden cross on 24 Jun 2026. Yet, the broader technical landscape presents a nuanced picture, with weekly indicators largely bullish but monthly momentum remaining bearish. This divergence raises questions about the strength and reliability of the signal in the current context.

Read full news article